Free Cash Flow for Edwards Lifesciences (EW)
Free Cash Flow for Edwards Lifesciences (EW): headline value $1.33B · YoY +360.5%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingFree Cash FlowSwitch metric
Latest period
$1.33B
YoY change
+360.5%
5Y CAGR
+15.6%
Peak year (2021)
$1.40B
Latest annual
$1.33B
Free Cash Flow history chart for Edwards Lifesciences (EW) from 1999 to 2025
Free Cash Flow history table for Edwards Lifesciences (EW) from 1999 to 2025
| Fiscal year | Period ended | Reported | Free Cash Flow | YoY |
|---|---|---|---|---|
| 2025 | $1.33B | +360.5% | ||
| 2024 | $289.90M | -53.9% | ||
| 2023 | $629.50M | -34.0% | ||
| 2022 | $953.40M | -32.0% | ||
| 2021 | $1.40B | +116.7% | ||
| 2020 | $647.00M | -28.2% | ||
| 2019 | $901.00M | +31.5% | ||
| 2018 | $685.10M | -17.0% | ||
| 2017 | $825.20M | +69.4% | ||
| 2016 | $487.00M | +9.9% | ||
| 2015 | $443.20M | -52.3% | ||
| 2014 | $928.60M | +156.1% | ||
| 2013 | $362.60M | +47.3% | ||
| 2012 | $246.10M | +9.9% | ||
| 2011 | $223.90M | +18.8% | ||
| 2010 | $188.40M | +86.0% | ||
| 2009 | $101.30M | +34.7% | ||
| 2008 | $75.20M | -49.1% | ||
| 2007 | $147.70M | -13.8% | ||
| 2006 | $171.40M | +94.1% | ||
| 2005 | $88.30M | -36.1% | ||
| 2004 | $138.10M | +63.6% | ||
| 2003 | $84.40M | +5.6% | ||
| 2002 | $79.90M | +26.8% | ||
| 2001 | $63.00M | -30.8% | ||
| 2000 | $91.00M | -32.1% | ||
| 1999 | $134.00M | — |
Free Cash Flow values are taken from Edwards Lifesciences's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual free cash flow for Edwards Lifesciences (EW) came in at $1.33B – surged 360.5% year-over-year.
Edwards Lifesciences free cash flow has recorded the values shown across consecutive periods, with a +15.6% compound annual growth rate over 2020–2025 (5 years).
Edwards Lifesciences free cash flow edged down from $1.40B in 2021 to $1.33B in 2025, a 4.8% drawdown.
Across the available history, free cash flow reached its high of $1.40B in 2021 and its low of $63.00M in 2001.
Among 8 Healthcare peers, Edwards Lifesciences (EW) ranks 9th; the peer median for free cash flow is $14.22B.
Edwards Lifesciences Free Cash Flow by Year
Edwards Lifesciences Free Cash Flow 2025: $1.33B
Edwards Lifesciences free cash flow in 2025 was $1.33B, surged 360.5% from 2024.
Edwards Lifesciences Free Cash Flow 2024: $289.90M
Edwards Lifesciences free cash flow in 2024 was $289.90M, plunged 53.9% below 2023.
Edwards Lifesciences Free Cash Flow 2023: $629.50M
Edwards Lifesciences free cash flow in 2023 was $629.50M, plunged 34.0% below 2022.
Edwards Lifesciences Free Cash Flow 2022: $953.40M
Edwards Lifesciences free cash flow in 2022 was $953.40M, plunged 32.0% below 2021.
Edwards Lifesciences Free Cash Flow 2021: $1.40B
Edwards Lifesciences free cash flow in 2021 was $1.40B.
See more financial history for Edwards Lifesciences (EW).
Sector peers — Free Cash Flow
Companies in the same sector as Edwards Lifesciences, ranked by their latest free cash flow.
| Company | Free Cash Flow | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $28.99B | Healthcare |
| Johnson & Johnson (JNJ) | $19.70B | Healthcare |
| AbbVie Inc. (ABBV) | $17.82B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $16.07B | Healthcare |
| Merck & Co., Inc. (MRK) | $12.36B | Healthcare |
| AstraZeneca PLC (AZN) | $11.77B | Healthcare |
| Eli Lilly and Company (LLY) | $8.97B | Healthcare |
| Amgen Inc. (AMGN) | $8.10B | Healthcare |
Frequently asked questions
What is Edwards Lifesciences's free cash flow?
Latest reported free cash flow for Edwards Lifesciences (EW) is $1.33B (period ending December 31, 2025).
How has Edwards Lifesciences free cash flow changed year-over-year?
Edwards Lifesciences (EW) free cash flow changed +360.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Edwards Lifesciences free cash flow?
Edwards Lifesciences (EW) free cash flow compound annual growth rate is +15.6% over the most recent 5 years available.
When did Edwards Lifesciences free cash flow hit its highest annual value?
Edwards Lifesciences free cash flow reached its highest annual value of $1.40B in 2021.
What was Edwards Lifesciences free cash flow in 2024?
Edwards Lifesciences (EW) free cash flow in 2024 was $289.90M.
What was Edwards Lifesciences free cash flow in 2025?
Edwards Lifesciences (EW) free cash flow in 2025 was $1.33B.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
EW Overview
Company profile, financial tools, and key metrics
EW Revenue Counter
Earns $199.88 every second. See per minute, hour, and day.
EW Earnings Counter
Earns $34.65 per second net profit. See per minute, hour, and day.
EW Economic Scale
Exceeds Fiji's GDP. Compare with world economies.
EW What If Invested
What if you had invested $1,000? See historical returns from any date.
EW How It Makes Money
Discover visual breakdown of $6.30B in revenue — where it comes from and where it goes.
EW Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
EW Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
EW Daily Price Character
Balanced · 50.0% historical win rate (green days). Streaks & record days.
EW Buybacks
0.93% TTM buyback yield. Shareholder yield & SBC comparison.
EW Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.